p.76 抽出テキスト

Kusumoto et al 2018 Bradycardia Clinical Practice Guidelines

Circulation. 2019;140:e382–e482. DOI: 10.1161/CIR.0000000000000628 August 20, 2019 e457 CLINICAL STATEMENTS AND GUIDELINES

S4.2.4-36.	Yeo KK, Li S, Amsterdam EA, et al. Comparison of clinical characteristics, treatments and outcomes of patients with ST-elevation acute myocardial infarction with versus without new or presumed new left bundle branch block (from NCDR(R)). Am J Cardiol. 2012;109:497–501. S4.2.4-37.	Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on Cardiac Pacing and Resynchronization Therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34:2281–329. S4.2.4-38.	Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/ AHA/HRS focused update incorporated into the ACCF/AHA/ HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2012;127: e283–352. S4.2.4-39.	Linzer M, Yang EH, Estes NA 3rd, et al. Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med. 1997;126:989–96. S4.2.4-40.	Akbar JJ, Meyer CA, Shipley RT, et al. Cardiopulmonary imaging in sarcoidosis. Clin Chest Med. 2008;29:429–43. viii. S4.2.4-41.	Blankenberg F, Eisenberg S, Scheinman MN, et al. Use of cine gradient echo (GRE) MR in the imaging of cardiac hemochromatosis. J Comput Assist Tomogr. 1994;18:136–8. S4.2.4-42.	Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009;53:1475–87. S4.2.4-43.	Kanao S, Tadamura E, Yamamuro M, et al. Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging. J Comput Assist Tomogr. 2005;29:745–8. S4.2.4-44.	Kondur AK, Li T, Vaitkevicius P, et al. Quantification of myocardial iron overload by cardiovascular magnetic resonance imaging T2* and review of the literature. Clin Cardiol. 2009;32:E55–9. S4.2.4-45.	Kouranos V, Hansell DM, Sharma R, et al. Advances in imaging of cardiopulmonary involvement in sarcoidosis. Curr Opin Pulm Med. 2015;21:538–45. S4.2.4-46.	Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186–93. S4.2.4-47.	Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol. 2005;75:241–7. S4.2.4-48.	Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969–77. S4.2.4-49.	Raney AR, Bello D. Cardiovascular magnetic resonance assessment of ischemic and nonischemic cardiomyopathies. Heart Fail Clin. 2006;2:145–61. S4.2.4-50.	Ruberg FL, Appelbaum E, Davidoff R, et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in lightchain cardiac amyloidosis. Am J Cardiol. 2009;103:544–9. S4.2.4-51.	Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med. 2001;110:520–7. S4.2.4-52.	Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45:1683–90. S4.2.4-53.	Sparrow PJ, Merchant N, Provost YL, et al. CT and MR imaging findings in patients with acquired heart disease at risk for sudden cardiac death. Radiographics. 2009;29:805–23. S4.2.4-54.	Stauder NI, Bader B, Fenchel M, et al. Images in cardiovascular medicine. Follow-up of cardiac sarcoidosis by magnetic resonance imaging. Circulation. 2005;111:e158–60. S4.2.4-55.	Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol. 2005;184:249–54. S4.2.4-56.	Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular mag-

netic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008;51:1022–30. S4.2.4-57.	Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/

ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006;48:1475–97. S4.2.4-58.	Anguera I, Miro JM, Evangelista A, et al. Periannular complications in infective endocarditis involving native aortic valves. Am J Cardiol. 2006;98:1254–60. S4.2.4-59.	Arnett EN, Roberts WC. Valve ring abscess in active infective endocarditis. Frequency, location, and clues to clinical diagnosis from the study of 95 necropsy patients. Circulation. 1976;54:140–5. S4.2.4-60.	Birmingham GD, Rahko PS, Ballantyne F 3rd. Improved detection of infective endocarditis with transesophageal echocardiography. Am Heart J. 1992;123:774–81. S4.2.4-61.	Choudhary SK, Bhan A, Reddy SC, et al. Aneurysm of sinus of Valsalva dissecting into interventricular septum. Ann Thorac Surg. 1998;65:735–40. S4.2.4-62.	Erbel R, Rohmann S, Drexler M, et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur Heart J. 1988;9:43–53. S4.2.4-63.	Shiga T, Wajima Z, Apfel CC, et al. Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis. Arch Intern Med. 2006;166:1350–6. S4.2.4-64.	Walters MI, Ettles D, Guvendik L, et al. Interventricular septal expansion of a sinus of Valsalva aneurysm: a rare cause of complete heart block. Heart. 1998;80:202–3. S4.2.4-65.	Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS

guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;136:e60–122.

4.2.5. Laboratory Testing in Patients With Documented or Suspected Bradycardia or Conduction Disorders S4.2.5-1.	 Chon SB, Kwak YH, Hwang SS, et al. Severe hyperkalemia can be detected immediately by quantitative electrocardiography and clinical history in patients with symptomatic or extreme bradycardia: a retrospective cross-sectional study. J Crit Care. 2013;28:1112. e7–13. S4.2.5-2.	 Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum. 1987;17:126–41. S4.2.5-3.	 Nakayama Y, Ohno M, Yonemura S, et al. A case of transient 2:1 atrioventricular block, resolved by thyroxine supplementation for subclinical hypothyroidism. Pacing Clin Electrophysiol. 2006;29:106–8. S4.2.5-4.	 Noble K, Isles C. Hyperkalaemia causing profound bradycardia. Heart. 2006;92:1063. S4.2.5-5.	 Wan D, Blakely C, Branscombe P, et al. Lyme carditis and high-

degree atrioventricular block. Am J Cardiol. 2018;121:1102–4.

4.2.6. Genetic Testing in Patients With Documented or Suspected Bradycardia or Conduction Disorders S4.2.6-1.	 Ishikawa T, Tsuji Y, Makita N. Inherited bradyarrhythmia: a diverse genetic background. J Arrhythm. 2016;32:352–8. S4.2.6-2.	 Joshi AK, Kowey PR, Prystowsky EN, et al. First experience with a Mobile Cardiac Outpatient Telemetry (MCOT) system for the diagnosis and management of cardiac arrhythmia. Am J Cardiol. 2005;95:878–81. S4.2.6-3.	 Smits JPP, Veldkamp MW, Wilde AAM. Mechanisms of inherited car-

diac conduction disease. EP Europace. 2005;7:122–37.

Downloaded from http://ahajournals.org by on October 7, 2026